Determinants of myocardial energetics and efficiency in symptomatic hypertrophic cardiomyopathy

Stefan A J Timmer1, Tjeerd Germans, Marco J W Götte

  • 1Department of Cardiology, 5F, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.

Insights

Hypertrophic cardiomyopathy (HCM) patients show reduced myocardial external efficiency (MEE) despite normal oxygen consumption. Stroke volume and left ventricular mass independently predict this impaired efficiency in HCM.

Area of Science:

  • Cardiology
  • Biomedical Imaging
  • Metabolic Research

Background:

  • Hypertrophic cardiomyopathy (HCM) is associated with myocardial energetic alterations beyond hypertrophy.
  • Previous studies suggest reduced myocardial external efficiency (MEE) in HCM, defined as external work (EW) relative to myocardial oxidative metabolism (MVO(2)).

Purpose of the Study:

  • To identify determinants of MEE in patients with HCM.
  • Utilize dynamic positron emission tomography (PET) and cardiovascular magnetic resonance imaging (CMR) for comprehensive assessment.

Main Methods:

  • Studied 20 HCM patients and 11 healthy controls using [(11)C]acetate PET for MVO(2) and CMR for left ventricular (LV) volumes and mass (LVM).
  • Employed univariate and multivariate analyses to identify independent predictors of myocardial efficiency.

Main Results:

  • HCM patients had significantly higher LVM (200 ± 76 g vs. 99 ± 21 g) and decreased MEE (21 ± 10% vs. 35 ± 8%) compared to controls.
  • MVO(2) and EW were comparable between groups.
  • MEE correlated with stroke volume (SV), LV outflow tract gradient, NT-proBNP, and free fatty acid levels; SV and LVM independently predicted MEE.

Conclusions:

  • HCM is characterized by unaltered MVO(2) but impaired EW generation per gram of myocardial tissue, leading to reduced MEE.
  • Stroke volume and left ventricular mass are independent predictors of mechanical external efficiency in HCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...